671 related articles for article (PubMed ID: 26616478)
1. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
Ding H; Kharboutli M; Saxena R; Wu T
Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
[TBL] [Abstract][Full Text] [Related]
2. Insulin-Like Growth Factor Binding Protein-4 as a Marker of Chronic Lupus Nephritis.
Wu T; Xie C; Han J; Ye Y; Singh S; Zhou J; Li Y; Ding H; Li QZ; Zhou X; Putterman C; Saxena R; Mohan C
PLoS One; 2016; 11(3):e0151491. PubMed ID: 27019456
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor binding protein-2 as a biomarker for lupus nephritis.
Luong PT; Nguyen TTD; Nguyen NT; Ngo HT; Nguyen HN; Pho DH; Nguyen HT
Pediatr Int; 2023; 65(1):e15613. PubMed ID: 37698235
[TBL] [Abstract][Full Text] [Related]
4. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
[TBL] [Abstract][Full Text] [Related]
5. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus.
Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y
J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413
[TBL] [Abstract][Full Text] [Related]
6. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
Yu KY; Yung S; Chau MK; Tang CS; Yap DY; Tang AH; Ying SK; Lee CK; Chan TM
Lupus; 2021 Jun; 30(7):1039-1050. PubMed ID: 33765901
[TBL] [Abstract][Full Text] [Related]
7. The role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis.
Alharazy SM; Kong NC; Mohd M; Shah SA; Abdul Gafor AH; Ba'in A
Clin Chim Acta; 2013 Oct; 425():163-8. PubMed ID: 23954775
[TBL] [Abstract][Full Text] [Related]
8. Human neutrophil peptide 1-3, a component of the neutrophil extracellular trap, as a potential biomarker of lupus nephritis.
Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
Int J Rheum Dis; 2015 Jun; 18(5):533-40. PubMed ID: 25196784
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of progranulin in patients with lupus nephritis and its correlation with disease activity.
Wu J; Wei L; Wang W; Zhang X; Chen L; Lin C
Rheumatol Int; 2016 Jun; 36(6):759-67. PubMed ID: 26968845
[TBL] [Abstract][Full Text] [Related]
10. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
11. Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis.
Yap DY; Yung S; Zhang Q; Tang C; Chan TM
Lupus; 2016 Jan; 25(1):46-53. PubMed ID: 26251400
[TBL] [Abstract][Full Text] [Related]
12. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
13. Periostin: a novel tissue biomarker correlates with chronicity index and renal function in lupus nephritis patients.
Wantanasiri P; Satirapoj B; Charoenpitakchai M; Aramwit P
Lupus; 2015 Jul; 24(8):835-45. PubMed ID: 25593049
[TBL] [Abstract][Full Text] [Related]
14. Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery Study.
Wu T; Ding H; Han J; Arriens C; Wei C; Han W; Pedroza C; Jiang S; Anolik J; Petri M; Sanz I; Saxena R; Mohan C
J Proteome Res; 2016 Jul; 15(7):2102-14. PubMed ID: 27211902
[TBL] [Abstract][Full Text] [Related]
15. Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis.
Shariati-Sarabi Z; Ranjbar A; Monzavi SM; Esmaily H; Farzadnia M; Zeraati AA
Int J Rheum Dis; 2013 Dec; 16(6):731-8. PubMed ID: 24382282
[TBL] [Abstract][Full Text] [Related]
16. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC
Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
[TBL] [Abstract][Full Text] [Related]
17. Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis.
Ding H; Shen Y; Lin C; Qin L; He S; Dai M; Okitsu SL; DeMartino JA; Guo Q; Shen N
Arthritis Res Ther; 2022 Mar; 24(1):77. PubMed ID: 35346341
[TBL] [Abstract][Full Text] [Related]
18. Serum thiols as a biomarker of disease activity in lupus nephritis.
Lalwani P; de Souza GK; de Lima DS; Passos LF; Boechat AL; Lima ES
PLoS One; 2015; 10(3):e0119947. PubMed ID: 25799079
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of neutrophil gelatinase-associated lipocalin and other laboratory markers for lupus nephritis: a cross-sectional investigation.
La'ulu SL; Suh-Lailam BB; Davis KW; Straseski JA; Tebo AE
Ann Clin Biochem; 2017 Mar; 54(2):240-245. PubMed ID: 27166308
[TBL] [Abstract][Full Text] [Related]
20. V-Set Immunoglobulin Domain-Containing Protein 4 as a Novel Serum Biomarker of Lupus Nephritis and Renal Pathology Activity.
Tang C; Zhang S; Teymur A; Yang B; Nazir F; Cai Q; Saxena R; Olsen NJ; Mohan C; Wu T
Arthritis Rheumatol; 2023 Sep; 75(9):1573-1585. PubMed ID: 37163449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
